… In addition, we present a new therapy for RA based on a … Prospects for the development
of pharmacologic regulators of placental growth factor, which is another angiogenic factor …

… review will focus on the opportunities and challenges of growth factor- and growth factor
receptor-targeted antiangiogenic drugs in the current clinical development of cancer therapy. …

… of the identified angiogenic growth factors in the development of therapeutic angiogenic …
intervention 40• 41, th re i concern over ob erved sy temic activity of admini tered growth factor …

… 36 Somatomedin C (IGF-I), TGF-B and B₂-microglobulin (originally designated as bone-derived
growth factor-II) are among the examples of such factors that are presumed to be …

… , such as basic fibroblast growth factor (bFGF), transforming growth factor beta (TGF-β),
vascular endothelial growth factor (VEGF), and platelet-derived growth factors (PDGFs). Second, …

… therapeutic agent, either alone or in combination with other agents such as epidermal growth
factor… and Tripathi, BJ: Prospects for epidermal growth factor therapy in the management of …

… kinase /^-selective inhibitors with excellent gastrointestinal absorption and little evident
toxicity are now available,17 opening the prospects for orally effective anti-VEGF therapies. …

… ) treatment are discussed. Normal and pathological wound healing process are observed
and the role of growth factors (… research suggests that treatment with single growth factor (GF) …

… and therapeutic interventions … prospects include the integration of various disease pathways
for the successful development of an early diagnosis and effective drugs for the treatment …

… Future prospects Overall, the consensus view is that the outlook for the use of growth
factors in wound healing is good. Although the improvements in healing observed in the small …